| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
24,941 |
22,972 |
$4.16M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,352 |
18,651 |
$3.13M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,196 |
16,420 |
$2.85M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,132 |
7,368 |
$2.78M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
24,904 |
7,616 |
$1.97M |
| G0378 |
Hospital observation service, per hour |
12,702 |
6,593 |
$1.88M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,039 |
4,790 |
$828K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,579 |
5,187 |
$630K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,580 |
4,112 |
$492K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,638 |
3,461 |
$480K |
| S9485 |
Crisis intervention mental health services, per diem |
895 |
660 |
$466K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,114 |
2,024 |
$376K |
| 64483 |
|
722 |
706 |
$309K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,773 |
3,730 |
$286K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,448 |
2,682 |
$282K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,856 |
1,749 |
$277K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,382 |
4,205 |
$275K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,143 |
5,506 |
$219K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
44,123 |
37,051 |
$207K |
| 80053 |
Comprehensive metabolic panel |
42,079 |
36,997 |
$205K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,085 |
786 |
$194K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,095 |
4,651 |
$193K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,055 |
2,322 |
$169K |
| 71046 |
Radiologic examination, chest; 2 views |
8,186 |
7,744 |
$166K |
| 97161 |
|
1,992 |
1,925 |
$144K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,159 |
1,087 |
$142K |
| 76830 |
Ultrasound, transvaginal |
1,092 |
1,074 |
$128K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,204 |
4,162 |
$124K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
6,194 |
6,078 |
$122K |
| 93971 |
|
488 |
460 |
$113K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,613 |
1,480 |
$102K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
854 |
802 |
$98K |
| 83690 |
|
21,824 |
19,361 |
$97K |
| 80050 |
General health panel |
5,077 |
4,971 |
$96K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,001 |
1,845 |
$94K |
| ATP14 |
|
11,018 |
9,240 |
$80K |
| 84484 |
|
10,632 |
7,827 |
$66K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
368 |
356 |
$65K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,769 |
7,523 |
$64K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,209 |
2,130 |
$62K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,186 |
2,108 |
$61K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
577 |
565 |
$61K |
| 80061 |
Lipid panel |
12,899 |
12,616 |
$56K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15,117 |
12,674 |
$55K |
| 64493 |
|
99 |
93 |
$50K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,284 |
8,103 |
$48K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,858 |
2,517 |
$48K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
322 |
309 |
$47K |
| 82607 |
|
4,852 |
4,760 |
$45K |
| 84703 |
|
7,305 |
6,792 |
$44K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,709 |
10,572 |
$42K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,441 |
6,954 |
$39K |
| 86317 |
|
925 |
903 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
943 |
898 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,327 |
6,021 |
$34K |
| 97162 |
|
773 |
733 |
$33K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
64 |
63 |
$32K |
| 87070 |
|
4,261 |
4,120 |
$32K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
169 |
67 |
$30K |
| Q0081 |
Infusion therapy, using other than chemotherapeutic drugs, per visit |
695 |
416 |
$29K |
| 84702 |
|
2,275 |
1,990 |
$28K |
| 82746 |
|
3,206 |
3,153 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,743 |
6,585 |
$28K |
| 83970 |
|
1,109 |
1,079 |
$28K |
| 74018 |
|
279 |
270 |
$27K |
| 83735 |
|
6,449 |
5,484 |
$25K |
| 83550 |
|
4,219 |
4,105 |
$25K |
| 73630 |
|
826 |
781 |
$24K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
68 |
63 |
$24K |
| 87400 |
|
1,386 |
1,267 |
$23K |
| 83880 |
|
1,626 |
1,457 |
$23K |
| 99218 |
|
55 |
31 |
$21K |
| 82728 |
|
2,178 |
2,123 |
$20K |
| 91300 |
|
45 |
45 |
$19K |
| 83540 |
|
4,300 |
4,179 |
$19K |
| 85610 |
|
7,270 |
6,063 |
$19K |
| 81001 |
|
8,892 |
8,245 |
$18K |
| 84439 |
|
2,757 |
2,664 |
$18K |
| 81513 |
|
158 |
152 |
$18K |
| 72100 |
|
764 |
733 |
$17K |
| 86618 |
|
1,312 |
1,278 |
$17K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,471 |
1,361 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
4,769 |
4,391 |
$16K |
| 87186 |
|
3,120 |
2,793 |
$16K |
| 73610 |
|
623 |
607 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
698 |
687 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,895 |
8,487 |
$15K |
| 76642 |
|
119 |
115 |
$14K |
| 85027 |
|
2,818 |
2,682 |
$13K |
| 86803 |
|
977 |
963 |
$12K |
| 59025 |
Fetal non-stress test |
48 |
27 |
$11K |
| 85730 |
|
2,382 |
2,256 |
$11K |
| 73564 |
|
559 |
523 |
$11K |
| 81003 |
|
6,812 |
6,395 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
26,128 |
20,626 |
$10K |
| 86780 |
|
898 |
885 |
$10K |
| 73130 |
|
447 |
428 |
$10K |
| 87469 |
|
461 |
447 |
$10K |
| 87468 |
|
462 |
448 |
$10K |
| 87478 |
|
461 |
447 |
$10K |
| 87484 |
|
461 |
447 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
835 |
808 |
$9K |
| 87481 |
|
236 |
152 |
$8K |
| 86141 |
|
808 |
767 |
$8K |
| 73030 |
|
327 |
314 |
$7K |
| ATP08 |
|
2,003 |
1,571 |
$7K |
| 87430 |
|
503 |
487 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,696 |
1,318 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
5,068 |
4,662 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
205 |
196 |
$6K |
| 87088 |
|
1,056 |
1,012 |
$6K |
| 0011A |
|
347 |
342 |
$5K |
| 85652 |
|
3,106 |
2,922 |
$5K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,931 |
7,586 |
$5K |
| 0012A |
|
333 |
332 |
$5K |
| 0031A |
|
198 |
195 |
$5K |
| 64484 |
|
16 |
16 |
$5K |
| 87147 |
|
775 |
687 |
$5K |
| 86850 |
|
610 |
577 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,677 |
7,644 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,740 |
2,597 |
$4K |
| 82043 |
|
1,520 |
1,471 |
$4K |
| ATP17 |
|
2,869 |
2,534 |
$4K |
| 84153 |
|
248 |
248 |
$4K |
| 87450 |
|
780 |
721 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,341 |
1,270 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
204 |
203 |
$3K |
| 87340 |
|
387 |
385 |
$3K |
| 83516 |
|
308 |
306 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
28 |
26 |
$3K |
| 81025 |
|
428 |
419 |
$2K |
| ATP03 |
|
1,059 |
913 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
12 |
$2K |
| 87077 |
|
705 |
590 |
$2K |
| 73110 |
|
73 |
72 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
15 |
14 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$2K |
| 87510 |
|
122 |
121 |
$2K |
| 87480 |
|
122 |
121 |
$2K |
| 87040 |
|
306 |
209 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$2K |
| 83605 |
|
403 |
362 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,343 |
1,316 |
$2K |
| 71250 |
|
102 |
93 |
$2K |
| 87660 |
|
111 |
109 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
95 |
89 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,224 |
4,876 |
$2K |
| 86900 |
|
673 |
634 |
$2K |
| 86901 |
|
670 |
631 |
$2K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
415 |
377 |
$2K |
| 86706 |
|
157 |
157 |
$2K |
| 96376 |
|
493 |
348 |
$2K |
| 85007 |
|
483 |
470 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,807 |
1,692 |
$1K |
| 77080 |
|
27 |
26 |
$1K |
| 0001A |
|
60 |
58 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,181 |
2,455 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
19 |
19 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,720 |
1,544 |
$1K |
| 82784 |
|
119 |
117 |
$1K |
| 0002A |
|
52 |
50 |
$1K |
| 64494 |
|
96 |
90 |
$1K |
| 80076 |
|
220 |
209 |
$958.17 |
| 86038 |
|
86 |
86 |
$931.21 |
| 86704 |
|
86 |
86 |
$898.70 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
24 |
15 |
$895.49 |
| 82550 |
|
284 |
267 |
$894.07 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
13 |
$861.68 |
| 84403 |
|
38 |
38 |
$842.12 |
| 90715 |
|
45 |
38 |
$747.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
164 |
137 |
$729.51 |
| 73502 |
|
97 |
92 |
$613.41 |
| 85651 |
|
229 |
226 |
$612.45 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
563 |
541 |
$597.69 |
| ATP15 |
|
107 |
83 |
$567.60 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
673 |
484 |
$550.59 |
| J2060 |
Injection, lorazepam, 2 mg |
1,475 |
1,242 |
$548.08 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
353 |
122 |
$518.89 |
| 82570 |
|
217 |
208 |
$509.29 |
| 83001 |
|
31 |
31 |
$495.06 |
| 74019 |
|
14 |
13 |
$472.98 |
| 93000 |
|
48 |
44 |
$466.19 |
| 84550 |
|
183 |
172 |
$450.68 |
| J1644 |
Injection, heparin sodium, per 1000 units |
129 |
62 |
$435.62 |
| 82962 |
|
2,936 |
1,139 |
$434.27 |
| 84460 |
|
161 |
156 |
$422.81 |
| 85379 |
|
51 |
50 |
$412.82 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
16 |
12 |
$394.64 |
| 82670 |
|
15 |
15 |
$374.65 |
| 84425 |
|
27 |
26 |
$341.80 |
| 86617 |
|
13 |
13 |
$327.84 |
| 86140 |
|
70 |
66 |
$318.33 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
657 |
503 |
$273.14 |
| 87205 |
|
76 |
71 |
$273.14 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
351 |
321 |
$254.62 |
| 84450 |
|
109 |
105 |
$229.88 |
| 88142 |
|
12 |
12 |
$214.44 |
| 83002 |
|
12 |
12 |
$195.96 |
| 86762 |
|
15 |
14 |
$190.35 |
| 96367 |
|
22 |
14 |
$181.65 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
265 |
234 |
$157.44 |
| 84100 |
|
225 |
185 |
$126.60 |
| 82565 |
|
53 |
52 |
$76.27 |
| 73080 |
|
12 |
12 |
$60.74 |
| 90686 |
|
39 |
39 |
$49.30 |
| 85045 |
|
12 |
12 |
$49.08 |
| ATP16 |
|
30 |
19 |
$33.46 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
17 |
13 |
$31.98 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
579 |
541 |
$25.00 |
| 82247 |
|
13 |
12 |
$22.80 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
438 |
375 |
$8.19 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
39 |
39 |
$5.23 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
96 |
94 |
$4.09 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
854 |
831 |
$3.92 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
224 |
204 |
$0.01 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
263 |
237 |
$0.01 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
18 |
16 |
$0.00 |
| 99221 |
|
95 |
94 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
3,576 |
3,048 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
27 |
24 |
$0.00 |
| 99152 |
|
45 |
41 |
$0.00 |
| 64495 |
|
19 |
19 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$0.00 |
| C1755 |
Catheter, intraspinal |
267 |
259 |
$0.00 |
| A9573 |
Injection, gadopiclenol, 1 ml |
69 |
64 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
230 |
207 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
18 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
37 |
37 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
30 |
26 |
$0.00 |
| 83615 |
|
19 |
19 |
$0.00 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
22 |
12 |
$0.00 |